CoChat

Symptom burden in cancer survivors 1 year after diagnosis: A report from the American Cancer Society's studies of cancer survivors.

Shi, Q., Smith, T., Michonski, J. D., Stein, K., Kaw, C., Cleeland, C. S. · 2010 · Journal of Clinical Oncology
Cited by 74

The DOI matches its Crossref record.

Abstract

9041 Background: Cancer survivors are at risk for persistent symptoms stemming from cancer and its treatment, but few studies have assessed the status of multiple symptoms after completion of cancer therapy. We describe symptom burden (SB), associated risk factors, and impact on quality of life (QoL) in a population-based sample of one-year cancer survivors. Methods: Cancer survivors were sampled from 11 state cancer registries and surveyed by telephone or mail approximately one year after diagnosis. Among 4,903 respondents who completed the Modified Rotterdam Symptom Checklist (RSCL-M) and Profile of Mood States-37 (POMS-37), 4,511 reported having symptoms. A two-step cluster analysis further divided those reporting symptoms into two subgroups: those with either low (n = 2,925) or high (n = 1,586) SB. Logistic regression identified medico-demographic risk factors for high SB. In survivors with high SB, symptom profiles were described using factor analysis. The impact of SB on QoL was estimated via ordered logistic regression with the QoL item from the Satisfaction with Life Domains Scale (SLDS) as the dependent variable. Results: Risk factors for high SB were: age less than 55 (OR = 1.92), lower income (OR = 1.62), lower education (OR = 1.30), uninsured/Medicaid (OR = 1.92), ≥1 comorbid condition (OR = 2.15), and previous chemotherapy (OR = 1.36). In survivors with high SB, factor analysis identified 7 factors among RSCL-M items, with fatigue and pain being the most severe. Among POMS-37 subscale items, fatigue and tension were the most severe. QoL was worse in survivors with high SB than in survivors with low SB (p<0.001), with pain and depression-related symptoms having the greatest impact on QoL. Conclusions: One in three cancer survivors reported high SB. Fatigue, pain, and depression were predominant among those with higher SB. The risk factors for high SB described above identified the groups of survivors most in need of symptom-management planning. High SB reported by survivors with minimal health insurance may have health policy implications. The negative impact of SB upon overall QoL underscores the importance of symptoms among survivors. No significant financial relationships to disclose.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2010.28.15_suppl.9041

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 74

Metadata

Authors
Shi, Q., Smith, T., Michonski, J. D., Stein, K., Kaw, C., & Cleeland, C. S.
Venue
Journal of Clinical Oncology
Published
2010-05-20
Volume
28
Issue
15_suppl
Pages
9041-9041
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W18308467
Cited by
74
References
0
Type
conference abstract
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Symptom burden in cancer survivors 1 year after diagnosis: A report from the American Cancer Society's studies of cancer survivors. https://app.cochat.ai/papers/10.1200/jco.2010.28.15_suppl.9041
The paper
Shi, Q., Smith, T., Michonski, J. D., Stein, K., Kaw, C., & Cleeland, C. S. (2010). Symptom burden in cancer survivors 1 year after diagnosis: A report from the American Cancer Society's studies of cancer survivors. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2010.28.15_suppl.9041

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.